Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Protexin Veterinary is a leading brand under ADM Protexin that specializes in the development and manufacture of innovative research-based probiotics and nutraceuticals for the veterinary market. The company focuses on companion animals, including dogs, cats, rabbits, and horses, providing solutions for gastrointestinal health, liver support, and urinary tract function. Their flagship products, such as Pro-Kolin and Synbiotic D-C, are widely recognized by veterinary professionals for managing digestive upsets and maintaining a healthy microbiome. Based in the United Kingdom, the company leverages advanced fermentation technologies and rigorous quality standards to deliver evidence-based supplements. Following its acquisition by ADM in 2018, Protexin Veterinary continues to expand its global footprint in the animal health sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Protexin Veterinary.